NHZ

Assay, Direct, Nucleic Acid Amplification, Parainfluenza Virus

Product code
NHZ
Device name
Assay, Direct, Nucleic Acid Amplification, Parainfluenza Virus
Device class
Class 1
21 CFR
21 CFR 866.3400
Medical specialty
Microbiology
Marketing pathway
510(K)
Flag
Third-party review eligible

FDA classification definition

These reagents are nucleic acid primers and probes for the amplification and identification of Parainfluenza virus directly from clinical specimens. The identification aids in the diagnosis of influenza and provides epidemiological information on this disease. This reagent differs from the description in the regulation in that it consists of nucleic acid primers and probes rather than antisera.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: NHZ
Classification and pathway per current FDA publications. Data from openFDA (CC0).